Related Articles
A HER2 bispecific antibody can be efficiently expressed in Escherichia coli with potent cytotoxicity
A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro
Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: Possible involvement in cancer-associated immunosuppression mechanism
COMPARISON OF ADHERENT LYMPHOKINE-ACTIVATED KILLER (A-LAK) CELLS GENERATED BY IL-2 AND IL-7 - CELLULAR MODIFICATIONS INDUCED BY IL-7
In vitro and in vivo antitumor effects of recombinant bispecific antibodies based on humanized anti-EGFR antibody